Showing results (41-50 of 129) with videos related to

Sort By:
Pageof 13
Oncotarget|September 29, 2018
STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2016
Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-Existing Liver and/or Renal DysfunctionKoji Sasaki, Amit Lahoti, Elias Jabbour, et al.
Oncotarget|May 17, 2018
STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 8, 2016
Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of MyelodysplasiaKoji Sasaki, Elias Jabbour, Jorge Cortes, et al.
The Lancet. Haematology|October 6, 2015
Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 studyPreetesh Jain, Hagop Kantarjian, Elias Jabbour, et al.
Haematologica|July 2, 2013
Assessment at 6 months may be warranted for patients with chronic myeloid leukemia with no major cytogenetic response at 3 monthsAziz Nazha, Hagop Kantarjian, Preetesh Jain, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2023
SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma?Shaoying Li, Guilin Tang, Preetesh Jain, et al.
International Journal of Cancer|July 20, 2017
Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.
Blood|September 14, 2011
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemiaXiao-Jie Yan, Igor Dozmorov, Wentian Li, et al.
The Lancet. Haematology|December 22, 2015
Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trialsKoji Sasaki, Sara S Strom, Susan O'Brien, et al.
Pageof 13